Product Information

NORTRIPTYLINE HCL 25 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1302 per EA under NDC 00093081101. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORTRIPTYLINE HCL 25 MG CAP

Nortriptyline Hydrochloride
$0.1302per EA

Strength

25 mg/1

NDC

00093081101

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NORTRIPTYLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074132

FDA Approved

3/27/1995

TE Code

AB

On Market Since

4/6/1995

Pharmacological Classes

Price Statistics

The NADAC for NORTRIPTYLINE HCL 25 MG CAP has been published 678 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1302 per EA
All-time high$0.1710 (Sep 10, 2025)
All-time low$0.0732 (May 22, 2024)
52-week high$0.1684
52-week low$0.1302
Median price$0.1172
Average price$0.1197
Largest weekly change+23.5% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-10.4%

1M

-16.6%

3M

-14.2%

6M

-17.6%

1Y

-23.4%

3Y

+47.2%

5Y

+18.4%

All

-1.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NORTRIPTYLINE HCL 25 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 25 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.1302 per EA (NDC 00093081101), effective Nov 18, 2026.

How has the price of NORTRIPTYLINE HCL 25 MG CAP changed over time?

Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has held within roughly two percent of its current level. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 25 MG CAP?

Since Nov 28, 2013, the NADAC for NORTRIPTYLINE HCL 25 MG CAP has ranged from a low of $0.0732 (May 22, 2024) to a high of $0.1710 (Sep 10, 2025), with a median of $0.1172 per EA.

Are there cheaper alternatives to NORTRIPTYLINE HCL 25 MG CAP?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NORTRIPTYLINE HCL 25 MG CAP, is $0.1047 per EA — about 20% below NORTRIPTYLINE HCL 25 MG CAP.

Who manufactures NORTRIPTYLINE HCL 25 MG CAP?

NORTRIPTYLINE HCL 25 MG CAP (NDC 00093081101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.